BIOMAT Database Logo BIOMAT Database Logo

S-adenosyl-l-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations. 2020

M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
Depression Clinical and Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Given the limitations of prescription antidepressants, many individuals have turned to natural remedies for the management of their mood disorders. We review three selected natural remedies that may be of potential use as treatments for depressive disorders and other psychiatric or neurological conditions. The best studied and best supported of these three remedies is S-adenosyl-l-methionine (SAMe), a methyl donor with a wide range of physiological functions in the human organism. With the increasing legalization of cannabis-related products, cannabidiol (CBD) has gained popularity for various potential indications and has even obtained approval in the United States and Canada for certain neurological conditions. Kratom, while potentially useful for certain individuals with psychiatric disorders, is perhaps the most controversial of the three remedies, in view of its greater potential for abuse and dependence. For each remedy, we will review indications, doses and delivery systems, potential anti-inflammatory and immunomodulatory action, adverse effects, and will provide recommendations for clinicians who may be considering prescribing these remedies in their practice.

UI MeSH Term Description Entries
D002170 Canada The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
D002185 Cannabidiol Compound isolated from Cannabis sativa extract. 1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-,Epidiolex
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders
D012436 S-Adenosylmethionine Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed) AdoMet,Ademetionine,FO-1561,Gumbaral,S Amet,S-Adenosyl-L-Methionine,S-Adenosylmethionine Sulfate Tosylate,SAM-e,Samyr,FO 1561,FO1561,S Adenosyl L Methionine,S Adenosylmethionine,S Adenosylmethionine Sulfate Tosylate
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D032065 Mitragyna A plant genus of the family RUBIACEAE. Members contain antimalarial (ANTIMALARIALS) and analgesic (ANALGESICS) indole alkaloids. Kratom,Mitragyna speciosa,Kratoms,Mitragyna speciosas,Mitragynas

Related Publications

M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
Blood S-adenosyl-L-methionine levels in psychiatric disorders.
February 1982, The American journal of psychiatry,
M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
[S-adenosyl-L-methionine (SAMe) and its use in hepatology].
January 1992, Minerva gastroenterologica e dietologica,
M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
Human blood kinetics of S-adenosyl-L-methionine (SAMe).
January 1978, Monographien aus dem Gesamtgebiete der Psychiatrie,
M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
S-adenosyl-L-methionine (SAMe) for smoking abstinence: a randomized clinical trial.
September 2012, Journal of alternative and complementary medicine (New York, N.Y.),
M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies.
January 1994, Acta neurologica Scandinavica. Supplementum,
M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
S-adenosyl-L-methionine (SAMe) and biogenic amine methylation processes.
January 1978, Monographien aus dem Gesamtgebiete der Psychiatrie,
M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
S-adenosyl-L-methionine (SAMe) blood levels in schizophrenia and depression.
January 1978, Monographien aus dem Gesamtgebiete der Psychiatrie,
M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
Effect of s-adenosyl-l-methionine (SAMe) upon depressive symptoms.
January 1976, Journal of psychiatric research,
M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
Pharmacokinetic studies of S-adenosyl-L-methionine (SAMe) in several animal species.
April 1976, Pharmacological research communications,
M Taylor Levine, and Jin Gao, and Senthil Kumaran Satyanarayanan, and Sarah Berman, and Jack T Rogers, and David Mischoulon
Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans.
November 2004, Pharmacotherapy,
Copied contents to your clipboard!